Sanofi Korea said its high-dose influenza vaccine Efluelda, designed for seniors, received marketing authorization from the Ministry of Food and Drug Safety on Nov. 29.Efluelda is the first high-dose influenza vaccine approved in Korea for the elderly, preventing influenza caused by type A and B vir
Celltrion said it has signed a joint research agreement with Cyron Therapeutics, a Korean company specializing in antibody discovery and development, for the development of cancer drugs based on multi-antibodies.Under the accord, Celltrion will provide target antibody clones to Cyron, and Cyron will
The Korean securities industry is revising upward the stock price targets for traditional pharmaceutical companies, pointing to licensing deals and export growth.As per the investment banking (IB) sector, domestic securities firms are upwardly adjusting target prices for major traditional pharmaceut
Kwangdong Pharmaceutical said it had signed a memorandum of understanding regarding the transfer of shares of BL Healthcare from BL Pharmtech, the largest shareholder.Under the accord, Kwangdong has agreed to acquire 58.74 percent of BL Healthcare from BL Pharmtech.The key provisions of the MOU incl
Korean pharmaceutical companies that have launched generic versions of AstraZeneca's SGLT-2 inhibitors Forxiga (dapagliflozin) and Xigduo (dapagliflozin-metformin hydrochloride) are facing difficulties promoting their products as they have been suspended from advertising these drugs.According to the
Jeil Pharmaceutical said Monday that it has launched Duglow Tab, a combination drug that blends dapagliflozin with pioglitazone, to treat type-2 diabetes.Duglow Tab combines the dapagliflozin, SGLT-2 inhibitor, and pioglitazone, thiazolidinedione (TZD).SGLT-2 inhibitors lower blood sugar by inhibiti
Bluemtec, a pharmaceutical e-commerce company, said it will start co-marketing two MSD’s vaccines -- one for hepatitis A the other for Measles, Mumps, and Rubella (MMR) –- in Korea from January 1, 2024.This marks the first joint vaccine sale between a local distributor and a global pharmaceutical co
Samil Pharmaceutical said Monday that its U.S. partner firm Biosplice Therapeutics confirmed the efficacy of Lorecivivint, a drug candidate for knee osteoarthritis, in a phase 3 study called OA-07. These results were recently revealed during the American College of Rheumatology (ACR) meeting held in
Novartis Korea said on Monday its biologic drug Cosentyx (secukinumab) will be covered by Korea’s national health insurance coverage as a first-line treatment for ankylosing spondylitis starting this month. According to the Ministry of Health and Welfare's directive, reimbursement for Cosentyx is ap
SLS Bio, a Kosdaq-listed developer of pharmaceuticals and diagnostic reagents, said it has entered into a contract with a global pharmaceutical company for the quality inspection and management testing of mRNA vaccines, without providing the name of the mutinational pharma. According to SLS Bio, the
Celltrion said Friday it submitted a marketing authorization application to the U.S. FDA for CT-P41, a biosimilar referencing Prolia (denosumab), aimed at treating osteoporosis and other related diseases.Prolia is an osteoporosis treatment developed by the multinational pharmaceutical giant Amgen. I
Daewoong Pharmaceutical said Friday that it has signed a contract with JSC Pharmasyntez, a Russian pharmaceutical company, to export diabetes drug Envlo (enavogliflozin) to Russia and five countries in the Commonwealth of Independent States (CIS) region.The contract is valued at approximately $60 mi
Pharmaceutical companies are trying to strengthen their competitiveness by combining original drug ingredients amid the competition for combination drugs to treat chronic diseases, such as hypertension and diabetes.On Tuesday, Handok received approval from the Ministry of Food and Drug Safety for it
GSK Korea said it conducted an internal campaign on Wednesday to improve awareness of human immunodeficiency virus (HIV) diseases in line with the upcoming "World AIDS (acquired immune deficiency syndrome) Day" on Dec. 1.World AIDS Day was established in January 1988 at the World Health Ministers' M
Ulcerative colitis, an incurable condition demanding continual therapeutic oversight marked by recurrent remissions and relapses, was discussed by Cheon Jae-hee, Professor of Gastroenterology at Severance Hospital, during a BMS Korea's media session on Wednesday."Ulcerative colitis requires treatmen
In the dynamic realm of pharmaceutical advancements, Merck has established itself as a global leader in infertility treatment, consistently setting new benchmarks through innovative therapies and groundbreaking research.Over recent years, Merck's commitment to addressing infertility has transformed
Daewoong Pharmaceutical said Wednesday it confirmed the safety of Dwj1563 in phase 1 clinical trials. Dwj1563 is a combination drug, mixing Envlo (enavogliflozin), designed to excrete sugar, with Zemiglo (gemigliptin), also known for its sugar-lowering properties.The phase 1 study served as a bioequ
Hanmi Pharm said Monday it has been selected as the No. 1 pharma company in the Korean Sustainability Index (KSI) for the fourth consecutive year at the “2023 Korea Sustainability Competition” organized by the Korea Standards Association (KSA).The KSI is an index that evaluates the sustainability of
JW Holdings said it has initiated the full-scale export of Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), to Mongolia through local pharmaceutical firm AsiaPharma LLC. TPN refers to the feeding of nutritional products to a person intravenously, bypassing the usual proce
Dong-A ST said Monday that it has received IND approval for a phase 1/2a clinical trial of its immuno-oncology drug, DA-4505, from the Ministry of Food and Drug Safety (MFDS), to treat solid tumors.The study will evaluate the safety and efficacy of DA-4505 monotherapy or in combination with the PD-1